Effects of Curcuminoids on Inflammatory and Oxidative Stress Biomarkers and Clinical Outcomes in Critically Ill Patients: A Randomized Double-Blind Placebo-Controlled Trial Publisher Pubmed



Zahedi H¹ ; Hosseinzadehattar MJ¹ ; Shadnoush M^{2, 3} ; Sahebkar A^{4, 5, 6} ; Barkhidarian B¹ ; Sadeghi O⁷ ; Najafi A⁸ ; Hosseini S¹ ; Qorbani M⁹ ; Ahmadi A⁸ ; Ardehali SH¹⁰ ; Norouzy A¹¹ Show Affiliations
Source: Phytotherapy Research Published:2021

Abstract

Experimental studies have suggested the beneficial effects of curcuminoids as natural polyphenols against traumatic brain injury (TBI). The aim of this study was to investigate the effects of supplementation with curcuminoids on inflammatory and oxidative stress biomarkers, clinical outcomes and nutritional status in critically ill patients with TBI. A total of 62 ICU-admitted adult patients with TBI were randomly allocated to receive either a daily dose of 500 mg curcuminoids or matched placebo via enteral nutrition for 7 consecutive days based on stratified block randomization by age and sex. Inflammatory and oxidative stress as well as clinical outcomes and nutritional status of the patients were measured at baseline and at the end of the study. There were no overall group effects regarding to all dependent variables. Compared with baseline, serum levels of IL-6, TNF-α, MCP-1 and CRP were significantly reduced in patients receiving curcuminoids (p <.05) without any significant changes in placebo group; however, changes in the activities of GPx and SOD in serum were not significant between two groups. Moreover, APACHEII and NUTRIC score were significantly improved following curcuminoids consumption in comparison with placebo (p <.05). The findings of this study suggest that short-term supplementation with curcuminoids may have beneficial effects on inflammation, clinical outcomes and nutritional status of critically ill patients with TBI. © 2021 John Wiley & Sons Ltd.